Why is neuroimmunopharmacology crucial for the future of addiction research?

Neuropharmacology

Volumn 76, Issue PART B, 2014, Pages 218-227

  Hutchinson, Mark R ^a   Watkins, Linda R ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chemokine; Cytokine; Glia; Innate immune; Toll like receptor

Indexed keywords

CHEMOKINE; CYTOKINE; DRUG METABOLITE; ENDOTOXIN; IBUDILAST; MINOCYCLINE; MORPHINE; NALOXONE; NALTREXONE; OPIATE; OPIATE ANTAGONIST; PATTERN RECOGNITION RECEPTOR; PROPENTOFYLLINE; PTI 609; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; XENOBIOTIC AGENT;

BIOTRANSFORMATION; BRAIN NUCLEUS; CENTRAL NERVOUS SYSTEM; CLINICAL RESEARCH; COGNITIVE THERAPY; DRUG DEPENDENCE; GLIA CELL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; INNATE IMMUNITY; MESOLIMBIC DOPAMINERGIC SYSTEM; NEUROIMMUNOPHARMACOLOGY; NEUROSCIENCE; NONHUMAN; PATTERN RECOGNITION; PHARMACODYNAMICS; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW; REWARD;

CHEMOKINE; CYTOKINE; GLIA; INNATE IMMUNE; LIPOPOLYSACCHARIDE; LPS; TLR; TOLL-LIKE RECEPTOR;

ALLERGY AND IMMUNOLOGY; ANIMALS; BIOMEDICAL RESEARCH; HUMANS; NEUROPHARMACOLOGY; SUBSTANCE-RELATED DISORDERS;

EID: 84887121400     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.05.039     Document Type: Review

References (87)

1. M.W. Adler, and T.J. Rogers Are chemokines the third major system in the brain? J. Leukoc. Biol. 78 2005 1204 1209 (Pubitemid 41779225)
2. M. Airavaara, J. Mijatovic, T. Vihavainen, T.P. Piepponen, M. Saarma, and L. Ahtee In heterozygous GDNF knockout mice the response of striatal dopaminergic system to acute morphine is altered Synapse 59 2006 321 329
3. M. Airavaara, A. Planken, H. Gäddnäs, T.P. Piepponen, M. Saarma, and L. Ahtee Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice Eur. J. Neurosci. 20 2004 2336 2344 (Pubitemid 39472396)
4. B.A. Baldo, and A.E. Kelley Discrete neurochemical coding of distinguishable motivational processes: insights from nucleus accumbens control of feeding Psychopharmacology (Berl.) 191 2007 439 459 (Pubitemid 46355910)
5. D. Beitner-Johnson, X. Guitart, and E.J. Nestler Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area J. Neurochem. 61 1993 1766 1773 (Pubitemid 23317200)
6. K.C. Berridge, and M.L. Kringelbach Neuroscience of affect: brain mechanisms of pleasure and displeasure Curr. Opin. Neurobiol. 23 2013 294 303
7. H. Berthold, J.F. Borel, and E. Flückiger Enigmatic action of ciclosporine A on the naloxone-precipitated morphine withdrawal syndrome in mice Neuroscience 31 1989 97 103 (Pubitemid 19209700)
8. H.O. Besedovsky, and A.D. Rey Physiology of psychoneuroimmunology: a personal view Brain Behav. Immun. 21 2007 34 44 (Pubitemid 44854450)
9. S.T. Bland, M.R. Hutchinson, S.F. Maier, L.R. Watkins, and K.W. Johnson The glial activation inhibitor AV411 reduces morphine-induced nucleus accumbens dopamine release Brain Behav. Immun. 23 2009 492 497
10. Y.A. Blednov, J.M. Benavidez, C. Geil, S. Perra, H. Morikawa, and R.A. Harris Activation of inflammatory signaling by lipopolysaccharide produces a prolonged increase of voluntary alcohol intake in mice Brain Behav. Immun. 25 2011 S92 S105
11. T. Borowski, L. Kokkinidis, Z. Merali, and H. Anisman Lipopolysaccharide, central in vivo biogenic amine variations, and anhedonia Neuroreport 9 1998 3797 3802 (Pubitemid 29189305)
12. M.M. Buchanan, M.R. Hutchinson, L.R. Watkins, and H. Yin Toll-like receptor 4 in CNS pathologies J. Neurochem. 114 2010 13 27
13. L.H. Burns, and H.-Y. Wang PTI-609: a novel analgesic that binds Filamin A to control opioid signaling Recent Patents CNS Drug Discov. 5 2010 210 220
14. A. Büttner Review: the neuropathology of drug abuse Neuropathol. Appl. Neurobiol. 37 2011 118 134
15. G.D. Cappon, L.L. Morford, and C.V. Vorhees Enhancement of cocaine-induced hyperthermia fails to elicit neurotoxicity Neurotoxicol. Teratol. 20 1998 531 535 (Pubitemid 28511115)
16. L. Capuron, and A.H. Miller Immune system to brain signaling: neuropsychopharmacological implications Pharmacol. Ther. 130 2011 226 238
17. L.S. Chaboub, and B. Deneen Developmental origins of astrocyte heterogeneity: the final frontier of CNS development Dev. Neurosci. 34 2012 379 388
18. G.Y. Chen, and G. Nunez Sterile inflammation: sensing and reacting to damage Nat. Rev. Immunol. 10 2010 826 837
19. Z.R. Chen, R.J. Irvine, A.A. Somogyi, and F. Bochner Mu receptor binding of some commonly used opioids and their metabolites Life Sci. 48 1991 2165 2171
20. J.K. Coller, and M.R. Hutchinson Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence Pharmacol. Ther. 134 2012 219 245
21. N. Dafny, P.M. Dougherty, and D. Drath Immunosuppressive agent modulates the severity of opiate withdrawal NIDA Res. Monogr. 105 1990 553 555
22. R. Dantzer, J.C. O'Connor, G.G. Freund, R.W. Johnson, and K.W. Kelley From inflammation to sickness and depression: when the immune system subjugates the brain Nat. Rev. Neurosci. 9 2008 46 56 (Pubitemid 350295688)
23. R. Dantzer, E. Satinoff, and K.W. Kelley Cyclosporine and alpha-interferon do not attenuate morphine withdrawal in rats but do impair thermoregulation Physiol. Behav. 39 1987 593 598 (Pubitemid 17069624)
24. R. Dantzer, E. Wollman, L. Vitkovic, and R. Yirmiya Cytokines and depression: fortuitous or causative association? Mol. Psychiatry 4 1999 328 332 (Pubitemid 29440571)
25. A. De, J.M. Krueger, and S.M. Simasko Tumor necrosis factor alpha increases cytosolic calcium responses to AMPA and KCl in primary cultures of rat hippocampal neurons Brain Res. 981 2003 133 142 (Pubitemid 37281228)
26. P.M. Dougherty, N.R. Pellis, and N. Dafny The brain and the immune system: an intact immune system is essential for the manifestation of withdrawal in opiate addicted rats Neuroscience 36 1990 285 289 (Pubitemid 20247095)
27. M.A. Erickson, K. Dohi, and W.A. Banks Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier Neuroimmunomodulation 19 2012 121 130
28. W.E. Fantegrossi, J.R. Ciullo, K.T. Wakabayashi, R. de La Garza, J.R. Traynor, and J.H. Woods A comparison of the physiological, behavioral, neurochemical and microglial effects of methamphetamine and 3,4- methylenedioxymethamphetamine in the mouse Neuroscience 151 2008 533 543
29. K. Hemstapat, L. Le, S.R. Edwards, and M.T. Smith Comparative studies of the neuro-excitatory behavioural effects of morphine-3-glucuronide and dynorphin A(2-17) following spinal and supraspinal routes of administration Pharmacol. Biochem. Behav. 93 2009 498 505
30. J.E. Holmes, and N.E. Miller Effects of bacterial endotoxin on water intake, food intake, and body temperature in the Albino rat J. Exp. Med. 118 1963 649 658
31. K. Hoshino, O. Takeuchi, T. Kawai, H. Sanjo, T. Ogawa, Y. Takeda, K. Takeda, and S. Akira Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product J. Immunol. 162 1999 3749 3752 (Pubitemid 29314747)
32. M.R. Hutchinson, S.T. Bland, K.W. Johnson, K.C. Rice, S.F. Maier, and L.R. Watkins Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward ScientificWorldJournal 7 2007 98 111 (Pubitemid 350292608)
33. M.R. Hutchinson, M. Buijs, J. Tuke, Y.H. Kwok, M. Gentgall, D. Williams, and P. Rolan Low-dose endotoxin potentiates capsaicin-induced pain in man: evidence for a pain neuroimmune connection Brain Behav. Immun. 30 2013 3 11
34. M.R. Hutchinson, B.D. Coats, S.S. Lewis, Y. Zhang, D.B. Sprunger, N. Rezvani, E.M. Baker, B.M. Jekich, J.L. Wieseler, A.A. Somogyi, D. Martin, S. Poole, C.M. Judd, S.F. Maier, and L.R. Watkins Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia Brain Behav. Immun. 22 2008 1178 1189
35. M.R. Hutchinson, A.L. Northcutt, L.W. Chao, J.J. Kearney, Y. Zhang, D.L. Berkelhammer, L.C. Loram, R.R. Rozeske, S.T. Bland, S.F. Maier, T.T. Gleeson, and L.R. Watkins Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia Brain Behav. Immun. 22 2008 1248 1256
36. M.R. Hutchinson, Y. Zhang, K. Brown, B.D. Coats, M. Shridhar, P.W. Sholar, S.J. Patel, N.Y. Crysdale, J.A. Harrison, S.F. Maier, K.C. Rice, and L.R. Watkins Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4) Eur. J. Neurosci. 28 2008 20 29
37. M.R. Hutchinson, S.S. Lewis, B.D. Coats, D.A. Skyba, N.Y. Crysdale, D.L. Berkelhammer, A. Brzeski, A. Northcutt, C.M. Vietz, C.M. Judd, S.F. Maier, L.R. Watkins, and K.W. Johnson Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast) Brain Behav. Immun. 23 2009 240 250
38. M.R. Hutchinson, S.S. Lewis, B.D. Coats, N. Rezvani, Y. Zhang, J.L. Wieseler, A.A. Somogyi, H. Yin, S.F. Maier, K.C. Rice, and L.R. Watkins Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences Neuroscience 167 2010 880 893
39. M.R. Hutchinson, Y. Zhang, M. Shridhar, J.H. Evans, M.M. Buchanan, T.X. Zhao, P.F. Slivka, B.D. Coats, N. Rezvani, J.L. Wieseler, T.S. Hughes, K.E. Landgraf, S. Chan, S. Fong, S. Phipps, J.J. Falke, L.A. Leinwand, S.F. Maier, H. Yin, K.C. Rice, and L.R. Watkins Evidence that opioids may have toll-like receptor 4 and MD-2 effects Brain Behav. Immun. 24 2010 83 95
40. M.R. Hutchinson, Y. Shavit, P.M. Grace, K.C. Rice, S.F. Maier, and L.R. Watkins Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia Pharmacol. Rev. 63 2011 772 810
41. M.R. Hutchinson, A.L. Northcutt, T. Hiranita, X. Wang, S.S. Lewis, J. Thomas, K. van Steeg, T.A. Kopajtic, L.C. Loram, C. Sfregola, E. Galer, N.E. Miles, S.T. Bland, J. Amat, R.R. Rozeske, T. Maslanik, T.R. Chapman, K.A. Strand, M. Fleshner, R.K. Bachtell, A.A. Somogyi, H. Yin, J.L. Katz, K.C. Rice, S.F. Maier, and L.R. Watkins Opioid activation of Toll-like receptor 4 contributes to drug reinforcement J. Neurosci. 32 2012 11187 11200
42. S.E. Hyman, R.C. Malenka, and E.J. Nestler Neural mechanisms of addiction: the role of reward-related learning and memory Annu. Rev. Neurosci. 29 2006 565 598 (Pubitemid 44476856)
43. S. Ikemoto Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex Brain Res. Rev. 56 2007 27 78 (Pubitemid 350110353)
44. A. Koch, L. Hamann, M. Schott, O. Boehm, D. Grotemeyer, M. Kurt, C. Schwenke, R.R. Schumann, S.R. Bornstein, and K. Zacharowski Genetic variation of TLR4 influences immunoendocrine stress response: an observational study in cardiac surgical patients Crit. Care 15 2011 R109
45. F.S. Labella, C. Pinsky, and V. Havlicek Morphine derivatives with diminished opiate receptor potency show enhanced central excitatory activity Brain Res. 174 1979 263 271 (Pubitemid 9229563)
46. N. Laflamme, and S. Rivest Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain J. Neurochem. 73 1999 309 321 (Pubitemid 29289140)
47. K. Landsteiner The Specificity of Serological Reactions 1936 C.C. Thomas Springfield, IL; Baltimore, MD
48. S.R. Laviolette, K. Nader, and D. van der Kooy Motivational state determines the functional role of the mesolimbic dopamine system in the mediation of opiate reward processes Behav. Brain Res. 129 2002 17 29 (Pubitemid 34059222)
49. S.S. Lewis, M.R. Hutchinson, N. Rezvani, L.C. Loram, Y. Zhang, S.F. Maier, K.C. Rice, and L.R. Watkins Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta Neuroscience 165 2010 569 583
50. S.S. Lewis, M.R. Hutchinson, Y. Zhang, D.K. Hund, S.F. Maier, K.C. Rice, and L.R. Watkins Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain Brain Behav. Immun. 30 2013 24 32
51. Y. Li, X. Sun, Y. Zhang, J. Huang, G. Hanley, K.E. Ferslew, Y. Peng, and D. Yin Morphine promotes apoptosis via TLR2, and this is negatively regulated by beta-arrestin 2 Biochem. Biophys. Res. Commun. 378 2009 857 861
52. L. Liu, J.K. Coller, L.R. Watkins, A.A. Somogyi, and M.R. Hutchinson Naloxone-precipitated morphine withdrawal behavior and brain IL-1β expression: comparison of different mouse strains Brain Behav. Immun. 25 2011 1223 1232
53. L. Liu, M.R. Hutchinson, J.M. White, A.A. Somogyi, and J.K. Coller Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence Pharmacogenet. Genomics 19 2009 869 876
54. M. Matic, A. Mahns, M. Tsoli, A. Corradin, P. Polly, and G.R. Robertson Pregnane X receptor: promiscuous regulator of detoxification pathways Int. J. Biochem. Cell. Biol. 39 2007 478 483 (Pubitemid 46096787)
55. W.J. McBride, J.M. Murphy, and S. Ikemoto Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies Behav. Brain Res. 101 1999 129 152 (Pubitemid 29236359)
56. A.H. Miller, V. Maletic, and C.L. Raison Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression Biol. Psychiatry 65 2009 732 741
57. T. Nakagawa, M. Fujio, T. Ozawa, M. Minami, and M. Satoh Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice Behav. Brain Res. 156 2005 233 239 (Pubitemid 39576063)
58. T. Nakagawa, and M. Satoh Involvement of glial glutamate transporters in morphine dependence Ann. N. Y. Acad. Sci. 1025 2004 383 388 (Pubitemid 39643885)
59. M. Narita, M. Miyatake, M. Narita, M. Shibasaki, K. Shindo, A. Nakamura, N. Kuzumaki, Y. Nagumo, and T. Suzuki Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 31 2006 2476 2488 (Pubitemid 44607065)
60. L.A.J. O'Neill The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress Immunol. Rev. 226 2008 10 18
61. T. Ozawa, T. Nakagawa, Y. Sekiya, M. Minami, and M. Satoh Effect of gene transfer of GLT-1, a glutamate transporter, into the locus coeruleus by recombinant adenoviruses on morphine physical dependence in rats Eur. J. Neurosci. 19 2004 221 226 (Pubitemid 38122088)
62. T. Ozawa, T. Nakagawa, K. Shige, M. Minami, and M. Satoh Changes in the expression of glial glutamate transporters in the rat brain accompanied with morphine dependence and naloxone-precipitated withdrawal Brain Res. 905 2001 254 258 (Pubitemid 32553863)
63. N.W. Palm, and R. Medzhitov Immunostimulatory activity of haptenated proteins Proc. Natl. Acad. Sci. U. S. A. 106 2009 4782 4787
64. S.-M. Park, R.P.A. Gaykema, and L.E. Goehler How does immune challenge inhibit ingestion of palatable food? Evidence that systemic lipopolysaccharide treatment modulates key nodal points of feeding neurocircuitry Brain Behav. Immun. 22 2008 1160 1172
65. R. Ranaldi, and R.J. Beninger Rostral-caudal differences in effects of nucleus accumbens amphetamine on VTA ICSS Brain Res. 642 1994 251 258 (Pubitemid 24105713)
66. S. Rivest Regulation of innate immune responses in the brain Nature 9 2009 429 439
67. 2+ mobilization and ROS generation in rat hippocampal astrocytes Neurochem. Int. 52 2008 1061 1067
68. M. Schäfer The painful Toll of ethanol and its metabolites: a new molecular pattern of recognition by Toll like receptors? Brain Behav. Immun. 30 2013 22 23
69. J.M. Schwarz, and S.D. Bilbo Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction J. Neurosci. 33 2013 961 971
70. J.M. Schwarz, M.R. Hutchinson, and S.D. Bilbo Early-life experience decreases drug-induced reinstatement of morphine CPP in adulthood via microglial-specific epigenetic programming of anti-inflammatory IL-10 expression J. Neurosci. 31 2011 17835 17847
71. D. Stellwagen, E.C. Beattie, J.Y. Seo, and R.C. Malenka Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha J. Neurosci. 25 2005 3219 3228 (Pubitemid 40463557)
72. K. Takagi, H. Fukuda, M. Watanabe, and M. Sato Studies on antitussives. III. (+)-Morphine and its derivatives J. Pharm. Soc. Japan 80 1960 1506 1509
73. J. Thomas, and M.R. Hutchinson Exploring neuroinflammation as a potential avenue to improve the clinical efficacy of opioids Expert Rev. Neurother. 12 2012 1311 1324
74. S. Tilleux, and E. Hermans Neuroinflammation and regulation of glial glutamate uptake in neurological disorders J. Neurosci. Res. 85 2007 2059 2070 (Pubitemid 47172138)
75. M.T. Tsuang, M.J. Lyons, J.M. Meyer, T. Doyle, S.A. Eisen, J. Goldberg, W. True, N. Lin, R. Toomey, and L. Eaves Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities Arch. Gen. Psychiatry 55 1998 967 972 (Pubitemid 28506837)
76. H. Vargas-Perez, R. Ting-A-Kee, C.H. Walton, D.M. Hansen, R. Razavi, L. Clarke, M.R. Bufalino, D.W. Allison, S.C. Steffensen, and D. van der Kooy Ventral tegmental area BDNF induces an opiate-dependent-like reward state in naive rats Science 324 2009 1732 1734
77. R. Wadachi, and K.M. Hargreaves Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection J. Dent. Res. 85 2006 49 53 (Pubitemid 43827762)
78. H.-Y. Wang, M. Frankfurt, and L.H. Burns High-affinity naloxone binding to filamin a prevents mu opioid receptor-Gs coupling underlying opioid tolerance and dependence PLoS One 3 2008 e1554
79. Q. Wang, H. Zhou, H. Gao, S.-H. Chen, C.-H. Chu, B. Wilson, and J.-S. Hong Naloxone inhibits immune cell function by suppressing superoxide production through a direct interaction with gp91phox subunit of NADPH oxidase J. Neuroinflammation 9 2012 32
80. X. Wang, L.C. Loram, K. Ramos, A.J. de Jesus, J. Thomas, K. Cheng, A. Reddy, A.A. Somogyi, M.R. Hutchinson, L.R. Watkins, and H. Yin Morphine activates neuroinflammation in a manner parallel to endotoxin Proc. Natl. Acad. Sci. U. S. A. 109 2012 6325 6330
81. Z. Wang, O. Pekarskaya, M. Bencheikh, W. Chao, H.A. Gelbard, A. Ghorpade, J.D. Rothstein, and D.J. Volsky Reduced expression of glutamate transporter EAAT2 and impaired glutamate transport in human primary astrocytes exposed to HIV-1 or gp120 Virology 312 2003 60 73 (Pubitemid 36918460)
82. L.R. Watkins, M.R. Hutchinson, K.C. Rice, and S.F. Maier The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia Trends Pharmacol. Sci. 30 2009 581 591
83. L.R. Watkins, and S.F. Maier Glia: a novel drug discovery target for clinical pain Nat. Rev. Drug Discov. 2 2003 973 985 (Pubitemid 37540579)
84. M. Weber, S. Modemann, P. Schipper, H. Trauer, H. Franke, P. Illes, K.D. Geiger, J.G. Hengstler, and W.J. Kleemann Increased polysialic acid neural cell adhesion molecule expression in human hippocampus of heroin addicts Neuroscience 138 2006 1215 1223 (Pubitemid 43363539)
85. R. Yirmiya, and I. Goshen Immune modulation of learning, memory, neural plasticity and neurogenesis Brain Behav. Immun. 25 2011 181 213
86. R. Yirmiya, Y. Pollak, M. Morag, A. Reichenberg, O. Barak, R. Avitsur, Y. Shavit, H. Ovadia, J. Weidenfeld, A. Morag, M.E. Newman, and T. Pollmächer Illness, cytokines, and depression Ann. N. Y. Acad. Sci. 917 2000 478 487
87. D.-H. Youn, H. Wang, and S.-J. Jeong Exogenous tumor necrosis factor-alpha rapidly alters synaptic and sensory transmission in the adult rat spinal cord dorsal horn J. Neurosci. Res. 86 2008 2867 2875